Adjunct Professor of Health Policy and Management
Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, is the Chair of the Department of Public Health and Health Technology Assessment at UMIT – University for Health Sciences, Medical Informatics and Technology in Austria and the Director of the Division for Public Health Decision Modeling, HTA, and Health Economics in the ONCOTYROL – Center for Personalized Cancer Medicine in Austria. He is also Adjunct Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health and Director of the Program on Cardiovascular Research at the Institute for Technology Assessment and Department of Radiology at the Massachusetts General Hospital, Harvard Medical School, Boston. He has an adjunct teaching appointment at the School of Public Health and Epidemiology at the University of Munich.
After medical school, Prof. Siebert worked for several years as a physician in international public health projects in West-Africa, Brazil, and Germany. He then earned an MPH at the Munich School of Public Health, and completed an MSc in Epidemiology and an ScD in Health Policy and Management with a concentration in decision sciences at the Harvard School of Public Health. Before he started his faculty position at Harvard Medical School, he was the Director of the Bavarian Public Health Research and Coordinating Center at the University of Munich, Germany, and completed Visiting Scholarship at the Harvard Center for Risk Analysis.
Prof. Siebert is Vice President-Elect of the Society of Medical Decision Making (SMDM), a member of the Latin America Consortium Advisory Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), a member of the ‘National HTA Strategy’ Expert Group of the Federal Ministry of Health in Austria, a member of the Advisory Board of the Ludwig Boltzmann Institute for Health Technology Assessment in Austria, a member of the Working Group “Methods of the Assessment of Cost-Benefit Relations” of the Scientific Advisory Board of IQWIG, a member of the Oncology Advisory Council of the Federal Ministry of Health in Austria, a member of the Austrian Cochrane Collaboration Branch, and he has served as a member of the ISPOR Board of Directors, a member of the SMDM Board of Trustees, and a member of the International Expert Committee Advising the Institute for Quality and Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of Health Care Interventions. He is the Chairman of the Working Groups “Health Economics” and “Medical Decision Making” of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS). He is Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force, Co-Chair of the “Issues in Methodology Section” of the SMDM Policy Initiative, and a Leadership Member of the ISPOR Personalized Medicine Special Interest Group. He teaches courses in decision analysis, HTA, economic evaluation, and advanced epidemiologic methods at several universities and for industry in Europe, USA, and South America. He advises government agencies, academic institutions and the industry regarding the conduction and impact of health technology assessments on policy and reimbursement decisions. He has authored more than 250 publications including HTA reports, textbook chapters, scientific articles, and editorials, and is Associate Editor of the International Journal of Public Health as well as editorial board member of several other scientific journals.
Prof. Siebert’s research interests include applying decision-analytic modeling, meta-analysis, quality-of-life assessment and cost-effectiveness analysis in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cardiovascular disease, diabetes, cancer, hepatitis C, HIV, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures as well as the development of causal decision models based on complex longitudinal data with time-varying interventions or exposures.
His research interests include applying evidence-based quantitative methods from public health, epidemiology, outcomes research, economic evaluation and decision sciences in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cancer, cardiovascular disease, diabetes, hepatitis C, HIV, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures, personalized medicine as well as the development of causal decision models.
|1980||B.Sc.||Gymnasium Giengen, Germany (Mathematics, Chemistry)|
|1991||M.D.||Ludwig-Maximilians-University of Munich, Germany|
|1996||Licensure to practice General Medicine, State of Bavaria, Germany|
|1996||M.P.H.||Postgraduate School of Public Health and Epidemiology, Ludwig-Maximilians-University of Munich, Germany|
|2000||S.M.||Master of Science in Epidemiology, Harvard School of Public Health, Boston, MA, USA|
|2002||Board Certificate in Epidemiology, German Society of Medical Informatics, Biostatistics and Epidemiology (GMDS)|
|2004||Board Certificate in Biostatistics in Medicine, German Society of Medical Informatics, Biostatistics and Epidemiology (GMDS)|
|2005||S.D.||Doctor of Science in Health Policy and Management, Harvard School of Public Health, Boston, MA, USA|
Honors and Distinctions
|1980||Robert Bosch Science Award|
|1996||Bavarian Public Health Award|
|1996||Fritz and Hildegard Berg Award for Public Health|
|1998||Pain Research Award|
|1999||Spitzner-Award Physical and Rehabilitative Medicine|
|1999||Pharmacoepidemiology Training and Research Scholarship, Dept. of Epidemiology, HSPH|
|1999||Paul Martini Research Award in Pharmacoepidemiology|
|2000||German Award for Pain Research|
|2002||Novartis Fellowship Award in the Program on the Economic Evaluation of Medical Technology (PEEMT), Harvard Center for Risk Analysis, HSPH|
|2003||German Cochrane Center and Deutsche Krankenversicherung (DKV): Award for Evidence-based Medicine|
|2004||Society of Medical Decision Making: Award for Outstanding Short Course|
|2004||International Society of Pharmacoeconomics and Outcomes Research: Poster Finalist Award|
|2008||German Society for Internal Medicine (DGIM): Award for Best Publication in Medizinische Klinik – Journal for Internal Medicine in Hospital and Private Practice 2007|
|2008||International Society of Pharmacoeconomics and Outcomes Research: Board of Directors Service Award|
|2009||David Sackett Award, German Network Evidence-Based Medicine|
|2009||Award for Best Short Course (Society of Medical Decision Making)|
|2010||SMDM Leadership and Service Award for SMDM Trustee, Methods Policy Liaison & 2010 European Meeting Chair with appreciation for leadership and service 2007-2010|
|2011||ISPOR Service Award as Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force and Co-Chair of the State-Transition Modeling Working Group|